Phase III study of Endari (L-glutamine oral powder) for the Treatment of Diverticulosis
Latest Information Update: 20 Jul 2020
At a glance
- Drugs Glutamine (Primary)
- Indications Diverticulitis
- Focus Therapeutic Use
- 20 Jul 2020 New trial record
- 16 Jul 2020 According to an Emmaus Life Sciences, Inc media release, based on data from ongoing phase I study, the company intends to pursue this trial under the FDA's abbreviated 505(b)(2) regulatory pathway.